Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-1,861
Closed -$74.8K 458
2024
Q2
$74.8K Hold
1,861
0.01% 165
2024
Q1
$74.6K Sell
1,861
-750
-29% -$28.2K 0.01% 143
2023
Q4
$98.3K Sell
2,611
-3,150
-55% -$96.3K 0.01% 129
2023
Q3
$160K Hold
5,761
0.02% 115
2023
Q2
$174K Hold
5,761
0.02% 117
2023
Q1
$178K Hold
5,761
0.02% 111
2022
Q4
$216K Sell
5,761
-157
-3% -$6.23K 0.04% 66
2022
Q3
$222K Buy
+5,918
New +$235K 0.18% 13
2022
Q2
Sell
-5,761
Closed -$282K 164
2022
Q1
$282K Hold
5,761
0.11% 29
2021
Q4
$276K Hold
5,761
0.09% 31
2021
Q3
$253K Hold
5,761
0.11% 26
2021
Q2
$253K Hold
5,761
0.15% 21
2021
Q1
$264K Buy
+5,761
New +$241K 0.03% 84
2020
Q1
Sell
-5,761
Closed -$226K 96
2019
Q4
$226K Hold
5,761
0.03% 88
2019
Q3
$206K Hold
5,761
0.03% 86
2019
Q2
$202K Buy
+5,761
New +$200K 0.03% 88

Other funds holding SNV

Godsey & Gibb Inc's SNV Position: Q3 2024 in Review

Godsey & Gibb Inc sold out of Synovus (SNV) in Q3 2024, closing a stake of 1,861 shares — an estimated $74.8K sold.

Godsey & Gibb Inc first reported a position in SNV in Q2 2019 and held it in 16 quarters. The position peaked at $282K in Q1 2022. 433 funds tracked by Wall St. Rank hold SNV as of Q3 2024.

  • Godsey & Gibb Inc reported no remaining Synovus position as of Q3 2024 after selling out during the quarter.
  • Godsey & Gibb Inc sold 1,861 Synovus shares in Q3 2024, an estimated $74.8K.
  • Godsey & Gibb Inc first reported a position in Synovus in Q2 2019 and held it in 16 quarters.
  • Godsey & Gibb Inc's Synovus position peaked at $282K in Q1 2022.
  • 433 funds tracked by Wall St. Rank held Synovus as of Q3 2024.

Based on Godsey & Gibb Inc's 13F filing for Q3 2024, filed 18 Oct 2024.